Trials / Recruiting
RecruitingNCT03949049
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Efficacy of Citicoline as Neuroprotector in Neonates Exposed to Hypoxia: A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 1 Month
- Healthy volunteers
- Not accepted
Summary
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Detailed description
Efficacy of Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Citicoline | Citacoline as neuroprotector |
| OTHER | Placebo | placebo group |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2029-12-01
- Completion
- 2029-12-01
- First posted
- 2019-05-14
- Last updated
- 2019-05-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03949049. Inclusion in this directory is not an endorsement.